CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences’ state-of-the-art facility follows all guidelines for Good Manufacturing Practices (GMP) and the Company’s full spectrum hemp extracts are processed, produced, and tested throughout the manufacturing process to confirm the cannabinoid content meets strict company standards. With a commitment to science, PlusCBD™ Oil was the first hemp CBD supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status.CV Sciences, Inc. has primary offices and facilities in San Diego, California.
Investors
Company Overview
Latest Financial Results
Q3 2022
Quarter Ended Sep 30, 2022
Latest 10-K
View Latest 10-KStock Information
Investor Contact Information
Company
CV Sciences, Inc.
9530 Padgett Street
Suite 107
San Diego, CA 92126
Toll-Free: 866-290-2157
F: 619-876-4321
info@cvsciences.com
Investor Relations
Transfer Agent
Issuer Direct
500 Perimeter Park Drive
Suite D
Morrisville, NC 27560
T: 919-481-4000
